연구동향 분석

High Cytoplasmic CXCR4 Expression Predicts Prolonged Survival in Triple-Negative Breast Cancer Patients Treated with Adjuvant Chemotherapy

심보배 진민선 문지혜 박인애 류한석 2018년

논문상세정보
인용/피인용

' High Cytoplasmic CXCR4 Expression Predicts Prolonged Survival in Triple-Negative Breast Cancer Patients Treated with Adjuvant Chemotherapy' 의 참고문헌

  • orrelation effect of EGFR and CXCR4 and CCR7 chemokine receptors in predicting breast cancer metastasis and prognosis
    Liu Y [2010]
  • Triplenegative breast cancer: challenges and opportunities of a heterogeneous disease
    Bianchini G [2016]
  • Triple-negative breast cancer: epidemiological considerations and recommendations
    Boyle P [2012]
  • The role of CXCR4 receptor expression in breast cancer: a large tissue microarray study
    Salvucci O [2006]
  • The influence of tumor-host interactions in the stromal cell-derived factor-1/CXCR4 ligand/receptor axis in determining metastatic risk in breast cancer
    Hassan S [2009]
  • Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion
    Orimo A [2005]
  • Stromal cell derived factor-1: its influence on invasiveness and migration of breast cancer cells in vitro, and its association with prognosis and survival in human breast cancer
    Kang H [2005]
  • Regulation of human chemokine receptors CXCR4. Role of phosphorylation in desensitization and internalization
    Haribabu B [1997]
  • Recruitment of regulatory T cells is correlated with hypoxia-induced CXCR4 expression, and is associated with poor prognosis in basal-like breast cancers
    Yan M [2011]
  • Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists clinical practice guideline update
    Wolff AC [2013]
  • Proposal for standardized definitions for efficacy end points in adjuvant breast cancer trials: the STEEP system
    Hudis CA [2007]
  • Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up
    Elston CW [1991]
  • Involvement of chemokine receptors in breast cancer metastasis
    Muller A [2001]
  • High level of CXCR4 in triplenegative breast cancer specimens associated with a poor clinical outcome
    Yu S [2013]
  • High chemokine receptor CXCR4 level in triple negative breast cancer specimens predicts poor clinical outcome
    Chu QD [2010]
  • Function of the chemokine receptor CXCR4 in haematopoiesis and in cerebellar development
    Zou YR [1998]
  • Expression pattern of stromal cell-derived factor-1 chemokine in invasive breast cancer is correlated with estrogen receptor status and patient prognosis
    Kobayashi T [2010]
  • Expression of CXCR4 and breast cancer prognosis: a systematic review and meta-analysis
    Zhang Z [2014]
  • Defects of B-cell lymphopoiesis and bone-marrow myelopoiesis in mice lacking the CXC chemokine PBSF/SDF-1
    Nagasawa T [1996]
  • Cytoplasmic CXCR4 high-expression exhibits distinct poor clinicopathological characteristics and predicts poor prognosis in triple-negative breast cancer
    Chen HW [2013]
  • Chemokines and leukocyte traffic
  • Cancer and the chemokine network
    Balkwill F [2004]
  • CXCR4 regulates growth of both primary and metastatic breast cancer
    Smith MC [2004]
  • CXCR4 inhibitors could benefit to HER2 but not to triple-negative breast cancer patients
    Lefort S [2017]
  • CXCL12/SDF1 expression by breast cancers is an independent prognostic marker of diseasefree and overall survival
    Mirisola V [2009]
  • CXCL12/CXCR4: a symbiotic bridge linking cancer cells and their stromal neighbors in oncogenic communication networks
    Guo F [2016]
  • CXCL12 chemokine and CXCR4 receptor: association with susceptibility and prognostic markers in triple negative breast cancer
  • American Society of Clinical Oncology/College Of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer
    Hammond ME [2010]
  • Advances in the systemic treatment of triple-negative breast cancer
    Lebert JM [2018]
  • A review on CXCR4/CXCL12 axis in oncology: no place to hide
    Domanska UM [2013]
  • A meta-analysis of CXCL12 expression for cancer prognosis
  • A CXCR4 antagonist CTCE-9908 inhibits primary tumor growth and metastasis of breast cancer
    Huang EH [2009]